Member Info for ratcliffewriter

Sir John turned to his secretary and said 'who's the fat bloke in the shell suit then?'

Very true Freddie. Many charlatans have become increasingly transparent...

Leading to CRUK taking on SCIB2 to trial at a cost of some 5 million quid to them. A slow burner of a relationship, but steadily warming up.

It shows just how long these 'eureka' discoveries take to get even close to fruition, and how rare a beast Scancell is. So many appear in articles like that and are never heard from again. Keep bucking that trend LD!

I seem to remember that Jason Luke was the one who (after the announcement of the SCIB1 combination trial plan) went on twitter and asked if he could be included in the work around the trial, and indeed was. Please correct me if wrong, but that's my recollection. Yet another top name attracted to Scancell.

Bull, the prodigal son, eventually got a job writing RNSs for VAL....so they say.

Indeed jonjo - if the company goes to the wall, think how much the BoD will lose in all the shares they own....oh hang on....

Just looking back at the Mystic of Dhaka licensing agreement RNS from 28th July 2017 - It says 'Mystic gains immediate access to ValiRx's patented technology for its further development by Mystic for the benefit of ValiRx, for a period of five years.'
It doesn't say if this is restricted to particular areas or if it is open door to anything Val has in development. Isn't this sort of deal likely to deter anyone from coming in with Val, as won't it mean Mystic have carte blanche to help themselves to any advances that a collaborator might assist in development, and Mystic would have no obligation to reciprocate. Have they shot themselves in the foot with the non-revenue generating Mystic deal?

Best wishes to you C7, sorry the news isn't so good, plenty here will wish you well and be rooting for you.

Josh Berlin says 'I am also a co-founder and serve on the organizing committee for the China Healthcare Dinner with C-Level Executives, held annually in San Francisco during the week of the JP Morgan Healthcare Conference.'
So which members of the BoD were at JP Morgan this year and last...? And was it something there that led to the invitation to present in China? And would that explain why RG went, given the way China does personal continuity? Just pondering...

His LinkedIn profile says - Analyst and strategist with extensive expertise on how China and Asia impact biopharma companies, investors and industry stakeholders. I currently serve as executive director and editor of new ventures for BioCentury, responsible for building our business, network and editorial opportunities in China and Asia. I am a co-founder and serve on the organizing committee for the annual BioCentury China Healthcare Summit in Shanghai. I am also a co-founder and serve on the organizing committee for the China Healthcare Dinner with C-Level Executives, held annually in San Francisco during the week of the JP Morgan Healthcare Conference. Prior to joining BioCentury, for 7 years I created and led the emerging markets group for Elsevier Business Intelligence (now part of Informa plc). In this role I directed our expansion into Asia markets, developed PharmAsia News, the annual PharmAsia Summit and related products, and built a customer base and large network of industry champions in the region, including China, India, Japan and Southeast Asia. I served as editorial, business development and strategy lead in Asia/emerging markets.  In addition, I played a leading role in creating EBI's social media strategy, including the creation of blog and Twitter sites that leveraged subscription-based publications and search engine optimization to generate and qualify sales leads. As a biopharma professional who has spent time on all ends of the information cycle - from analysis, to product development, to consulting - I have a unique perspective on what it takes to create differentiated content that customers value and rely upon to drive business decisions. Specialties: China, Asia, South Korea, India, Japan, emerging markets, biotech, pharma, publishing, analysis, social media, business development, product development

Not now darling...

There will be a referendum to vote for a return to Scancell debate as of tomorrow morning...

Tozerk/January - wonder if there's a vacancy for a cleaner at that office they've been renting in Boston for the last 3 years or more? Must be inches deep in dust by now.

January - you missed out 'attending conferences' (presumably staying in decent hotels and flying business class to get there) and 'discussions with big pharmas and financiers' - possibly just discussing things like 'do you find Emirates more comfortable than Virgin'' or 'do you think the buffet is better than last year's or not', but discussing nonetheless. For three grand a week I'd expect you to do these couple of extra things - if it isn't too much trouble of course...

If anyone wants to see the results of extreme left wing politics and state control versus capitalism, just compare the development of Russia with that of America from 1917 to now. Neither is perfect, but where would you rather have lived in any 80 year period between 1917 and the present day? Although of course when you mention that (or Venezuela today) to the lefties they will tell you that those weren't 'proper' socialism. Strange how if you wanted to talk up fascism and said that Nazi Germany was only bad because it wasn't 'proper' fascism everyone rightly dismisses you as delusional. A few scales need to fall from a few eyes, as ever.

Very true - people always fall for the 'free nice and shiny stuff and the idea that 'the state will pay' without stopping to think where the state's money actually comes from. Corbyn is dangerous in the extreme, one can only hope for a Labour split but while the Conservatives are is disarray they will feign unity in the hope of power at any price. With any less barking leader they'd be 20 points ahead, but even a minority communist government would be a nightmare for many years.

Agreed agema - I imagine very few could see her leading another election campaign after the dog's dinner of her last effort, so her days were effectively numbered even then.

'People's vote' is a lefty term used to make 'second referendum' sound less like the usual EU method of 'keep having referenda until you get the result you want.' Presumably a second referendum that was 52 percent in favour of remaining would be 'democracy in action', whereas the other way round is not. Somehow...

Sorry about the Croydon thing. Anyway, hope the wrist recovers. And you are wrong about GF, but at least that's one thing you have been consistent about.